3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
118
Carcinoma, Non-Small-Cell Lung
27
Skin Neoplasms
21
Colorectal Neoplasms
17
Lung Neoplasms
16
Sarcoma
15
Carcinoma, Renal Cell
15
Breast Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Pancreatic Neoplasms
13
Ovarian Neoplasms
13
Neoplasms
13
Carcinoma, Merkel Cell
12
Urinary Bladder Neoplasms
11
Prostatic Neoplasms
11
Neoplasm Metastasis
11
Head and Neck Neoplasms
11
Carcinoma, Basal Cell
11
Stomach Neoplasms
10
Carcinoma, Hepatocellular
10
Uterine Cervical Neoplasms
8
Thyroid Neoplasms
8
Lymphoma, T-Cell, Cutaneous
8
Mycosis Fungoides
7
Esophageal Neoplasms
7
Brain Neoplasms
7
Recurrence
6
Lymphoma, Large-Cell, Anaplastic
6
Lymphoma
6
Gastrointestinal Neoplasms
6
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colitis
×
Dermatologic
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled